Ammar Adam
Impact in
- Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
Papers in
-
- Chromatin Remodeling and Cancer 4
- Cell death mechanisms and regulation 3
- Protein Degradation and Inhibitors 2
-
- Cancer Mechanisms and Therapy 5
- Co-authors
- Moses M. Kasembeli (1 shared paper)Melissa D. Landis (1 shared paper)Lacey E. Dobrolecki (1 shared paper)Chad J. Creighton (1 shared paper)David Torres (1 shared paper)Bhuvanesh Dave (1 shared paper)Uddalak Bharadwaj (1 shared paper)T. Kris Eckols (1 shared paper)
- Journals
- Blood (4 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Clinical Cancer Research (1 paper)Current Cancer Drug Targets (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Ammar Adam
15 papers receiving 365 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 72
- Toxicology 17
- Hepatology 35
- Immunology 80
- Oncology 101
Countries citing papers authored by Ammar Adam
This map shows the geographic impact of Ammar Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ammar Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ammar Adam more than expected).
Fields of papers citing papers by Ammar Adam
This network shows the impact of papers produced by Ammar Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ammar Adam. The network helps show where Ammar Adam may publish in the future.
Co-authors
The 25 scholars most cited alongside Ammar Adam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 137 | |
| 2 | 2015 | 57 | |
| 3 | 2020 | 42 | |
| 4 | 2016 | 27 | |
| 5 | 2010 | 26 | |
| 6 | 2015 | 19 | |
| 7 | 2017 | 15 | |
| 8 | 1977 | 14 | |
| 9 | 2016 | 10 | |
| 10 | 2018 | 8 | |
| 11 | 2014 | 6 | |
| 12 | 2014 | 4 | |
| 13 | 2014 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2023 | 0 | |
| 17 | 2023 | 0 |
About Ammar Adam
Ammar Adam is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Immunology, Hepatology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 371 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), Phagocytosis and Immune Regulation (4 papers), Chromatin Remodeling and Cancer (4 papers), Liver physiology and pathology (4 papers), Cell death mechanisms and regulation (3 papers), Erythrocyte Function and Pathophysiology (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Pharmacology (72 citations), Toxicology (17 citations), Hepatology (35 citations), Immunology (80 citations) and Oncology (101 citations). Ammar Adam has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Moses M. Kasembeli, Melissa D. Landis, Lacey E. Dobrolecki, Chad J. Creighton, David Torres, Bhuvanesh Dave, Uddalak Bharadwaj, T. Kris Eckols, Michael T. Lewis and Judy C. Chang. Their work appears in journals such as Blood, Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research and Current Cancer Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.